Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1371-1380 of 2916 for cancer

Edit search filters
  1. A Study Of TAK-981 In Combination With Rituximab In Participants With Relapsed/Refractory (R/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL)

    Rochester, MN

  2. A Study To Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant In Participants With Newly Diagnosed Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  3. Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate Gilteritinib Vs. Midostaurin In FLT3 Mutated Acute Myeloid Leukemia

    Jacksonville, FL, Rochester, MN

  5. Phase II Venetoclax, Obinutuzumab And Bendamustine In High Tumor Burden Follicular Lymphoma As Front Line Therapy

    Rochester, MN

  6. S0820, Adenoma and Second Primary Prevention Trial

    Rochester, MN

  7. Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma

    Rochester, MN

  8. Apixaban In Preventing Secondary Cancer Related Blood Clots In Cancer Patients Who Have Completed Anticoagulation Therapy

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, Rochester, MN

  9. Study Evaluating The Safety And Effectiveness Of JCARH125 In Subjects With Relapsed And/or Refractory Multiple Myeloma (EVOLVE)

    Rochester, MN

  10. Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures after Endotherapy

    Jacksonville, FL

.

Mayo Clinic Footer